The Wall Street Journal just published an article on Hyperthermia’s resurgence in the medical scene. Although the report lacks to mention some of the fantastic results that this therapy produces in cervical, bladder, pancreatic, melanoma, ovarian, breast, esophageal, prostate, and head/neck cancers (to name a few), it at minimum brings hyperthermia back in the spotlight. READ THE ARTICLE
The article mentions some studies in the ’90s where outcomes were not as stellar as they are today. This may be due to early lab built equipment, and inadequate protocols had much to do with that data. Today, with our BSD-500 Superficial/Interstitial and BSD-2000 Deep Regional systems at the center of many critical phase III medical trials, results can be 2 to 3 times greater when adding hyperthermia to chemotherapy and radiotherapy.
Immunology is the real story here. The body is an efficient cancer-fighting device. Heating the cancerous tumors to fever temperatures (42-42˚C) appears to unmask cancer from the body's immune system. We will see the results of this ongoing research and study of the immunological effect soon.